The longevity biotech industry revolves around the goal of increasing the period of life that a person spends in good health. There has been a rapidly expanding effort in recent years to develop drugs that target aging as a root cause of disease, and this type of biotechnology has come to be a very popular focus for many companies, leading to numerous anti-aging biotech startups popping up around the world.
The primary technology used when developing anti-aging therapies is epigenetic reprogramming, which involves the identification of specific sets of transcription factors that can induce changes in gene expression and cellular behavior. This effectively reverses or modifies the epigenetic markers associated with aging, rejuvenating cells and tissues, and potentially slowing down or reversing the effects of aging, and even age-related diseases, such as neurodegenerative diseases.
This technology has been tested in animal models, and there is evidence that it works, sparking considerable investment in startups seeking to rejuvenate humans. Here, in alphabetical order, we take a look at eight anti-aging biotech companies on a mission to extend lives and make age-related diseases, a thing of the past.